Sugi Predict

Sugi Predict / Compounds / SCHEMBL1047699

SCHEMBL1047699

SCHEMBL1047699

CCCCCCCCCCCCCC(=O)CC(CCCCCC(=O)O)C(=O)CCCCCCCCCCCCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.59
▸ MAPT P10636 2/20 0.59
▸ FFAR4 Q5NUL3 2/20 0.57
▸ FFAR1 O14842 2/20 0.57
▸ GPR84 Q9NQS5 8/20 0.55
▸ PPARG P37231 7/20 0.55
▸ PPARD Q03181 7/20 0.55
▸ PPARA Q07869 7/20 0.55
▸ HDAC11 Q96DB2 5/20 0.55
▸ TSHR P16473 4/20 0.55
▸ PTPN1 P18031 3/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ TLR2 O60603 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ FABP4 P15090 2/20 0.55
▸ ALOX15 P16050 2/20 0.55
▸ HSD17B10 Q99714 2/20 0.55
▸ SLC22A6 Q4U2R8 1/20 0.55
▸ SLC22A8 Q8TCC7 1/20 0.55
▸ MEN1 O00255 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1047282 1.00 KMT2A (0.59) KMT2AMAPTFFAR4FFAR1GPR84
SCHEMBL933152 0.97 KMT2A (0.59) KMT2AMAPTFFAR4FFAR1GPR84
SCHEMBL933570 0.92 KMT2A (0.56) KMT2AMAPTFFAR4FFAR1GPR84
SCHEMBL933504 0.92 PPARG (0.62) KMT2AMAPTFFAR4FFAR1PPARG
SCHEMBL933603 0.92 PPARG (0.62) KMT2AMAPTFFAR4FFAR1PPARG
SCHEMBL933601 0.92 PPARG (0.62) KMT2AMAPTFFAR4FFAR1PPARG
SCHEMBL933503 0.92 PPARG (0.62) KMT2AMAPTFFAR4FFAR1PPARG
SCHEMBL934025 0.89 PPARG (0.62) KMT2AMAPTFFAR4FFAR1PPARG
SCHEMBL934023 0.89 PPARG (0.62) KMT2AMAPTFFAR4FFAR1PPARG
SCHEMBL1962661 0.88 FFAR4 (0.67) KMT2AMAPTFFAR4FFAR1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4734964-A1 LIPID PARTICLES FOR DELIVERING A PAYLOAD Repertoire Immune Medicines, Inc. (US) 2026-05-06 — — EP claimed
WO-2025007024-A1 LIPID PARTICLES FOR DELIVERING A PAYLOAD Repertoire Immune Medicines, Inc. (US) 2025-01-02 — — WO claimed
EP-4734964-A1 LIPID PARTICLES FOR DELIVERING A PAYLOAD Repertoire Immune Medicines, Inc. (US) 2026-05-06 — — EP disclosed
WO-2025007024-A1 LIPID PARTICLES FOR DELIVERING A PAYLOAD Repertoire Immune Medicines, Inc. (US) 2025-01-02 — — WO disclosed
US-11541010-B2 Amphoteric liposomes comprising imino lipids BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2023-01-03 — — US disclosed
US-20200330384-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2020-10-22 — — US disclosed
EP-2823810-B9 Amphoteric liposomes comprising imino lipids NOVOSOM VERWALTUNGS GMBH (DE) 2019-10-30 — — EP disclosed
EP-2823810-B1 Amphoteric liposomes comprising imino lipids NOVOSOM VERWALTUNGS GMBH (DE) 2019-03-27 — — EP disclosed
US-20180338919-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS NOVOSOM AG (DE) 2018-11-29 — — US disclosed
US-10039714-B2 Imino compounds for amphoteric liposomes and uses thereof NOVOSOM VERWALTUNGS GMBH (DE) 2018-08-07 — — US disclosed
EP-2451440-B2 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH INC (US) 2018-03-14 — — EP disclosed
US-20140178462-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS MARINA BIOTECH, INC. (US) 2014-06-26 — — US disclosed
US-20120237589-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS MARINA BIOTECH, INC. (US) 2012-09-20 — — US disclosed
EP-2462924-A2 Improvements in or relating to amphoteric liposomes. Marina Biotech, Inc. (US) 2012-06-13 — — EP disclosed
EP-2277508-B1 Emulation of lipoprotein structures MARINA BIOTECH INC (US) 2012-04-25 — — EP disclosed
EP-2277508-A1 Emulation of lipoprotein structures Marina Biotech, Inc. (US) 2011-01-26 — — EP disclosed
US-20100330154-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS MARINA BIOTECH, INC. 2010-12-30 — — US disclosed
EP-2211840-A2 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS novosom AG (DE) 2010-08-04 — — EP disclosed
WO-2009047006-A2 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS NOVOSOM AG (DE) 2009-04-16 — — WO disclosed
WO-2008155141-A2 NOVEL FACULTATIVE CATONIC STEROLS NOVOSOM AG (DE) 2008-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11541010-B2 Amphoteric liposomes comprising imino lipids SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885FFAR4 1821/4885
US-20120237589-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885FFAR4 1821/4885
US-10039714-B2 Imino compounds for amphoteric liposomes and uses thereof IPO8, IPO7, PHOSPHO1 KMT2A 2901/4885MAPT 4444/4885FFAR4 2858/4885
US-20200330384-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885FFAR4 1821/4885
US-20100330154-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS LIPA, CETP, SGMS1 KMT2A 866/4885MAPT 2723/4885FFAR4 2480/4885
US-20180338919-A1 AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS SGMS1, SGMS2, PHOSPHO1 KMT2A 3600/4885MAPT 4693/4885FFAR4 1821/4885
US-20140178462-A1 AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS LIPA, CETP, SGMS1 KMT2A 866/4885MAPT 2723/4885FFAR4 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.